Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes

Molecular and Cellular Proteomics

Volumn 7, Issue 8, 2008, Pages 1420-1433

  Gonçalves, Anthony ^a,b,c   Charafe Jauffret, Emmanuelle ^a,b,c   Bertucci, François ^a,b   Audebert, Stéphane ^a   Toiron, Yves ^a   Esterni, Benjamin ^c   Monville, Florence ^a   Tarpin, Carole ^a   Jacquemier, Jocelyne ^a,c   Houvenaeghel, Gilles ^b,c   Chabannon, Christian ^b,c   Extra, Jean Marc ^a   Viens, Patrice ^a,b   Borg, Jean Paul ^a,b   Birnbaum, Daniel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CALGRANULIN B; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; UBIQUITIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CLASSIFICATION; CARBOXY TERMINAL SEQUENCE; CLINICAL FEATURE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DNA MICROARRAY; EARLY CANCER; GENE EXPRESSION PROFILING; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TISSUE MICROARRAY; UPREGULATION;

BREAST NEOPLASMS; CALGRANULIN B; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN;

EID: 50249182832     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M700487-MCP200     Document Type: Article

References (45)

1. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O., and Botstein, D. (2000) Molecular portraits of human breast tumours. Nature 406, 747-752
2. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., and Borresen-Dale, A. L. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98, 10869-10874
3. Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., Demeter, J., Perou, C. M., Lonning, P. E., Brown, P. O., Borresen-Dale, A. L., and Botstein, D. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sch U. S. A. 100, 8418-8423
4. Troester, M. A., Hoadley, K. A., Sorlie, T., Herbert, B. S., Borresen-Dale, A. L., Lonning, P. E., Shay, J. W., Kaufmann, W. K., and Perou, C. M. (2004) Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res. 64, 4218-4226
5. Bertucci, F., Finetti, P., Rougemont, J., Charafe-Jauffret, E., Cervera, N., Tarpin, C., Nguyen, C., Xerri, L., Houlgatte, R., Jacquemier, J., Viens, P., and Bimbaum, D. (2005) Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res. 65, 2170-2178
6. Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hass, K. R., Stec, J., Ayers, M., Wagner, P., Morandi, P., Fan, C., Rabiul, I., Ross, J. S., Hortobagyi, G. N., and Pusztai, L. (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res. 11, 5678-5685
7. Sotiriou, C., Neo, S. Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., and Liu, E. T. (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc. Alatl. Acad Sci. U. S. A. 100, 10393-10398
8. Charafe-Jauffret, E., Ginestier, C., Monville, F., Finetti, P., Adelaide, J., Cervera, N., Fekairi, S., Xerri, L., Jacquemier, J., Birnbaum, D., and Bertucci, F. (2006) Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25, 2273-2284
9. Bertucci, F., Birnbaum, D., and Goncalves, A. (2006) Proteomics of breast cancer: principles and potential clinical applications. Mol. Cell. Proteomics 5, 1772-1786
10. Petricoin, E. F., and Liotta, L. A. (2004) SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 15, 24-30
11. Kozak, K. R., Amneus, M. W., Pusey, S. M., Su, F., Luong, M. N., Luong, S. A., Reddy, S. T., and Farias-Eisner, R. (2003) Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc. Natl. Acad. Sci. U. S. A. 100, 12343-12348
12. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., and Liotta, L. A. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577
13. Zhang, Z., Bast, R. C., Jr., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., Berchuck, A., van Haaften-Day, C., Hacker, N. F., de Bruijn, H. W. A., van der Zee, A. G. J., Jacobs, I. J., Fung, E. T., and Chan, D. W. (2004) Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 64, 5882-5890
14. Goncalves, A., Esterni, B., Bertucci, F., Sauvan, R., Chabannon, C., Cubizolles, M., Bardou, V. J., Houvenaegel, G., Jacquemier, J., Granjeaud, S., Meng, X. Y., Fung, E. T., Birnbaum, D., Maraninchi, D., Viens, P., and Borg, J. P. (2006) Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 25, 981-989
15. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95, 14863-14868
16. Shevchenko, A., Wilm, M., Vorm, O., Jensen, O. N., Podtelejnikov, A. V., Neubauer, G., Mortensen, P., and Mann, M. (1996) A strategy for identifying gel-separated proteins in sequence databases by MS alone. Biochem. Soc. Trans. 24, 893-896
17. Jaulin-Bastard, F., Saito, H., Le Bivic, A., Ollendorff, V., Marchetto, S., Birnbaum, D., and Borg, J.-P. (2001) The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins. J. Biol. Chem. 276, 15256-15263
18. Jacquemier, J., Ginestier, C., Rougemont, J., Bardou, V. J., Charafe-Jauffret, E., Geneix, J., Adelaide, J., Koki, A., Houvenaeghel, G., Hassoun, J., Maraninchi, D., Viens, P., Birnbaum, D., and Bertucci, F. (2005) Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res. 65, 767-779
19. Kaplan, E. L., and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481
20. Ross, D. T., and Perou, C. M. (2001) A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis. Markers 17, 99-109
21. Bertucci, F., Finetti, P., Cervera, N., Charafe-Jauffret, E., Mamessier, E., Adelaide, J., Debono, S., Houvenaeghel, G., Maraninchi, D., Viens, P., Charpin, C., Jacquemier, J., and Birnbaum, D. (2006) Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 66, 4636-4644
22. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J. P., Tong, F., Speed, T., Spellman, P. T., DeVries, S., Lapuk, A., Wang, N. J., Kuo, W. L., Stilwell, J. L., Pinkel, D., Albertson, D. G., Waldman, F. M., McCormick, F., Dickson, R. B., Johnson, M. D., Lippman, M., Ethier, S., Gazdar, A., and Gray, J. W. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527
23. Mani, A., and Gelmann, E. P. (2005) The ubiquitin-proteasome pathway and its role in cancer. J. Clin. Oncol. 23, 4776-4789
24. Chen, C., Seth, A. K, and Aplin, A. E. (2006) Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer. Mol. Cancer Res. 4, 695-707
25. Hoeller, D., Hecker, C. M., and Dikic, I. (2006) Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 6, 776-788
26. Iwaya, K., Ogawa, H., Mukai, Y., Iwamatsu, A., and Mukai, K. (2003) Ubiquitin-immunoreactive degradation products of cytokeratin 8/1B correlate with aggressive breast cancer. Cancer Sci. 94, 864-870
27. Wu, J. Y., Vlastos, A. T., Pelte, M. F., Caligo, M. A., Bianco, A., Krause, K. H., Laurent G. J., and Irminger-Finger, I. (2006) Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis. Int. J. Cancer 118, 1215-1226
28. Slotky, M., Shapira, M., Ben-Izhak, O., Linn, S., Futerman, B., Tsalic, M., and Hershko, D. (2005) The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res. 7, R737-R744
29. Burger, A. M., Gao, Y., Amemiya, Y., Kahn, H. J., Kitching, R., Yang, Y., Sun, P., Narod, S. A., Hanna, W. M., and Seth, A. K. (2005) A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res. 65, 10401-10412
30. Ricolleau, G., Charbonnel, C., Lode, L., Loussouam, D., Joalland, M. P., Bogumil, R., Jourdain, S., Minvielle, S., Campone, M., Deporte-Fety, R., Campion, L., and Jezequel, P. (2006) Surface-enhanced laser desorption/ ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors. Proteomics 6, 1963-1975
31. Miyoshi, Y., Nakayama, S., Torikoshi, Y., Tanaka, S., Ishihara, H., Taguchi, T., Tamaki, Y., and Noguchi, S. (2006) High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci. 97, 523-529
32. Vijay-Kumar, S., Bugg, C. E., Wilkinson, K. D., and Cook, W. J. (1985) Three-dimensional structure of ubiquitin at 2.8 Å resolution. Proc. Natl. Acad. Sci. U. S. A. 82, 3582-3585
33. Reyes-Turcu, F. E., Horton, J. R., Mullally, J. E., Heroux, A., Cheng, X., and Wilkinson, K. D. (2006) The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 124, 1197-1208
34. Wilkinson, K. D., and Audhya, T. K. (1981) Stimulation of ATP-dependent proteolysis requires ubiquitin with the COOH-terminal sequence Arg-Gly-Gly. J. Biol. Chem. 256, 9235-9241
35. Gebhardta, C., Németha, J., Angel, P., and Hesse, J. (2006) S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72, 1622-1631
36. El-Rifai, W., Moskaluk, C. A., Abdrabbo, M. K., Harper, J., Yoshida, C., Riggins, G. J., Frierson, H. F., Jr., and Powell, S. M. (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 62, 6823-6826
37. Arai, K., Teratani, T., Nozawa, R., and Yamada, T. (2001) Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. Oncol. Rep. 8, 591-596
38. Arai, K., Yamada, T., and Nozawa, R. (2000) Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. Med. Oncol. 17, 183-188
39. Ott, H. W., Lindner, H., Sarg, B., Mueller-Holzner, E., Abendstein, B., Bergant, A., Fessler, S., Schwaerzler, P., Zeimet, A., Marth, C., and Illmensee, K. (2003) Calgranulins in cystic fluid and serum from patients with ovarian carcinomas. Cancer Res. 63, 7507-7514
40. Cross, S. S., Hamdy, F. C., Deloulme, J. C., and Rehman, I. (2005) Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46, 256-269
41. Hiratsuka, S., Watanabe, A., Aburatani, H., and Maru, Y. (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375
42. Petricoin, E. F., III, Ornstein, D. K., Paweletz, C. P., Ardekani, A., Hackett, P. S., Hitt, B. A., Velassco, A., Trucco, C., Wiegand, L., Wood, K., Simone, C. B., Levine, P. J., Linehan, W. M., Emmert-Buck, M. R., Steinberg, S. M., Kohn, E. C., and Liotta, L. A. (2002) Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 94, 1576-1578
43. Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P., Larsen, P. H., White, B. C., Roberts, J. R., Edgerton, M., Gonzalez, A., Nadaf, S., Moore, J. H., Caprioli, R. M., and Carbone, D. P. (2003) Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362, 433-439
44. Schwartz, S. A., Weil, R. J., Johnson, M. D., Toms, S. A., and Capdoli, R. M. (2004) Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin. Cancer Res. 10, 981-987
45. Schwartz, S. A., Weil, R. J., Thompson, R. C., Shyr, Y., Moore, J. H., Toms, S. A., Johnson, M. D., and Caprioli, R. M. (2005) Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res. 65, 7674-7681